Oral exposure to citrinin significantly exacerbates the pathophysiology of a mouse model of imiquimod-induced psoriasis via direct activation of dendritic cell

J Appl Toxicol. 2023 Sep;43(9):1284-1292. doi: 10.1002/jat.4462. Epub 2023 Mar 20.

Abstract

Citrinin, a mycotoxin produced by Penicillium citrinum and Penicillium verrucosum, mainly contaminates cereals. The aim of study was to investigate the novel immunoreactive effect of citrinin using a mouse model of psoriasis. A mouse model of psoriasis was generated by topical application of 5% imiquimod in female BALB/c mice. Standard rodent diet and rice samples with 3 ppm of citrinin were mixed to obtain a final citrinin concentration of 0.3 ppm, and a citrinin-contaminated diet was fed to mice daily. Skin thickness, scratching behavior, and trans epidermal water loss (TEWL) were monitored continuously during the imiquimod application. Immediately after the final imiquimod application, ear skin and auricular lymph node (LN) were sampled for further analysis. Only a slight increase was observed in skin thickness in the citrinin exposure group; however, citrinin exposure significantly exacerbated hyperkeratinization and inflammatory cell infiltration in histological evaluation. TEWL, which is representative of cutaneous barrier function, was significantly increased by citrinin exposure. In terms of immune function, the number of immune cells in LN (T cells and dendritic cells) and gene expression of interleukin (IL)-17 in skin tissue were significantly increased by citrinin exposure. Direct interaction of dendritic cells (DCs) in citrinin-induced psoriasis development was further examined by proinflammatory cytokine determination in THP-1 cells and murine bone marrow derived DCs. IL-6 and/or tumor necrosis factor α were significantly increased by citrinin exposure. Taken together, our results imply that oral exposure to citrinin exacerbates the symptoms of a mouse model of psoriasis via direct activation of DCs.

Keywords: IL-17; TNFα; citrinin; dendritic cell; mycotoxin; psoriasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoquinolines / metabolism
  • Aminoquinolines / toxicity
  • Animals
  • Citrinin* / metabolism
  • Citrinin* / toxicity
  • Dendritic Cells
  • Disease Models, Animal
  • Female
  • Imiquimod / toxicity
  • Mice
  • Mice, Inbred BALB C
  • Psoriasis* / chemically induced
  • Skin

Substances

  • Imiquimod
  • Citrinin
  • Aminoquinolines